Trade Summary

10 months ago, Coleman Mark, serving as Dir at Axsome Therapeutics, Inc. (AXSM), purchased 1,575 shares at $127.28 per share, for a total transaction value of $200,466.00. Following this transaction, Coleman Mark now holds 452,068 shares of AXSM.

The trade was executed on Monday, September 8, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, September 9, 2025 at 8:11 PM ET, 1 day after the trade was made.

Axsome Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.